Cargando…

PO-1198 Changes in radical radiotherapy for lung cancer patients in the UK during the COVID-19 pandemic.

Detalles Bibliográficos
Autores principales:	croxford, W., Banfill, K., Fornacon-Wood, I., Britten, A., Carson, C., Hatton, M., Thippu Jayaprakash, K., Jegannathen, A., Keng Koh, P., Panakis, N., Peedell, C., Pope, A., Powell, C., Stilwell, C., Thomas, B., Wood, V., Yun Zhou, S., Price, G., Faivre-Finn, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ireland Ltd. 2021
Materias:	Digital Poster: Lung
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755625/ http://dx.doi.org/10.1016/S0167-8140(21)07649-0

Ejemplares similares

203MO Changes in management for patients with lung cancer treated with radical radiotherapy during the first wave of the COVID-19 pandemic in the UK (COVID-RT Lung)
por: Banfill, K., et al.
Publicado: (2021)

Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK
por: Banfill, K., et al.
Publicado: (2022)

P09.17 Changes in the Management of Patients Having Radical Radiotherapy in the UK During the COVID-19 Pandemic (COVID-RT Lung)
por: Banfill, K., et al.
Publicado: (2021)

Changes in management for patients with lung cancer referred for radical radiotherapy during the first wave of the COVID 19 pandemic in the UK (COVID-RT Lung)
por: Banfill, Kathryn Banfill, et al.
Publicado: (2021)

PO-1179 Radiation induced pneumonitis during COVID-19: artificial intelligence for differential diagnosis.
por: Ippolito, E., et al.
Publicado: (2021)

PO-1249 The impact of COVID-19 pandemic in the lung cancer treatment in a radiotherapy service
por: Costa, S., et al.
Publicado: (2022)

PO-1165 Dosimetric parameters in hypofractionated radiotherapy in NSCLC cohort during SARS-COV-2 pandemia
por: González Ruiz, M.A., et al.
Publicado: (2021)

PO-1181 Hypofractionation in NSCLC as the new standard of care during SARS-CoV-2 pandemia.
por: Vera Barragán, V., et al.
Publicado: (2021)

PO-1174 3-weekly paclitaxel-carboplatin with radiation for stage III NSCLC – option during COVID-19 pandemic
por: Wong, H., et al.
Publicado: (2021)

PO-1528 Mood disorder in cancer patients undergoing radiotherapy during the COVID-19 outbreak
por: Nardone, V., et al.
Publicado: (2021)

PO-1058 Estimating the carbon footprint of the radiotherapy pathway and changes in response to COVID-19
por: Cummings, J., et al.
Publicado: (2022)

PO-1060 Survival Analysis for Whole Lung Radiation in Patients with Acute Respiratory Syndrome for COVID-19
por: Ortiz Arce, C.S., et al.
Publicado: (2022)

PO-1327 Prostate cancer radiotherapy in a COVID-19 pandemic year: experience of a chilean public hospital
por: Letelier, H., et al.
Publicado: (2021)

PO-1480 Implementation of a self-administered patient health history questionnaire in a radiation oncology department during COVID-19.
por: Houlihan, O., et al.
Publicado: (2021)

Radiomics as a personalized medicine tool in lung cancer: Separating the hope from the hype
por: Fornacon-Wood, Isabella, et al.
Publicado: (2020)

PO-1476 Covid-19 era and radiotherapy: psychological changes in oncological patients
por: Caliandro, M., et al.
Publicado: (2021)

PO-1524 On how COVID-19 has affected radiation therapy treatments
por: Ambroa Rey, E.M., et al.
Publicado: (2021)

PO-1494 Universal testing for SARS-Cov-2 in patients undergoing anticancer treatment.
por: Guerini, A.E., et al.
Publicado: (2021)

PO-1420 iCARE: sarcoma patient radiotherapy experience during COVID-19
por: McCabe, H., et al.
Publicado: (2021)

PO-1059 The contribution of hypofractionated radiotherapy during the COVID 19 pandemic
por: Dhouib, F., et al.
Publicado: (2022)

PO-1441 Remote monitoring during radiotherapy – recruitment for an eHealth study under the Covid19 pandemic
por: Pappot, H., et al.
Publicado: (2022)

Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)
por: Taylor, Sally, et al.
Publicado: (2021)

PO-1484 Impact of COVID-19 pandemic on Radiation Oncology practice. An overview of recent higher quality reports
por: Carbonara, R., et al.
Publicado: (2021)

PO-1514 Prospective assessment of employees stress during the COVID-19 pandemic
por: Guckenberger, M., et al.
Publicado: (2021)

PO-1517 Which impact of the COVID-19 pandemic on residents training in radiotherapy?
por: Fourati, N., et al.
Publicado: (2021)

PO-1505 Phone call triage for patients admission in a radiotherapy department during COVID 19 pandemic
por: Santo, B., et al.
Publicado: (2021)

PO-1506 Psychological impact of COVID 19 pandemic in cancer patients: a cross sectional observational study
por: SANTO, B., et al.
Publicado: (2021)

PO-1070 Impact of COVID-19 in cancer patients: Analysis of the first 20 months in 13 Spanish Centers
por: Romero, S., et al.
Publicado: (2022)

Temporomandibular Disorders and Headache: A Retrospective Analysis of 1198 Patients
por: Di Paolo, Carlo, et al.
Publicado: (2017)

Impact of Introducing Intensity Modulated Radiotherapy on Curative Intent Radiotherapy and Survival for Lung Cancer
por: Fornacon-Wood, Isabella, et al.
Publicado: (2022)

PO-1561 Low Dose Radiation Therapy for COVID-19 Pneumonia: Risk of Cancer with AP-PA fields and IMRT
por: Sharma, D.N., et al.
Publicado: (2022)

PO-1464 Impact of COVID-19 on Radiation Oncology, an Austrian Experience
por: Mangesius, J., et al.
Publicado: (2021)

Modeling the Cost-Effectiveness of Adjuvant Osimertinib for Patients with Resected EGFR-mutant Non-Small Cell Lung Cancer
por: Lemmon, Christopher A, et al.
Publicado: (2022)

PO-1461 Impact of the COVID-19 pandemic on Radiation Oncology Departments in Brazil
por: Yoshinari Jr, G.H., et al.
Publicado: (2021)

Bronchial epithelial cells cultured from clinically stable lung allograft patients promote the development of macrophages from monocytes rather than dendritic cells
por: Ward, C, et al.
Publicado: (2009)

PO-1100 Implementation of FAST-Forward during COVID19: Report of acute skin toxicity /resource implications
por: Nugent, K., et al.
Publicado: (2021)

Planning and Evaluating Remote Consultation Services: A New Conceptual Framework Incorporating Complexity and Practical Ethics
por: Greenhalgh, Trisha, et al.
Publicado: (2021)

Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic
por: Faivre-Finn, C., et al.
Publicado: (2020)

The evolving role of radiotherapy in non-small cell lung cancer
por: Brown, Sean, et al.
Publicado: (2019)

PO-1000 Any impact of COVID-19 pandemic on the features of the Head and Neck (HN) cancer patients?
por: Yanes, B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qmv5h3k8paseqc4kk9a6bgg244